{"SPADE_UN_22447": {"Sequence Information": {"Peptide Name": "M-Cecropin-B [M12V], HB12, SB-37 AMD", "Sequence": "MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG", "Sequence Length": 38, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P01508", "uniprotUrl": "http://www.uniprot.org/uniprot/P01508", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Short bioactive peptides", "Pubmed ID": "", "Reference": "PATENT US 6875744B2. 2005;:", "Author": "Owen DR, Kenner LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}, {"Title": "Antimicrobial peptide therapeutics for cystic fibrosis.", "Pubmed ID": "15980369", "Reference": "Antimicrob Agents Chemother. 2005;49:2921-2927", "Author": "Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15980369"}], "Mass": 4088.95, "PI": 10.73, "Net Charge": 7, "Hydrophobicity": -0.01, "Frequent Amino Acids": "KAG", "Absent Amino Acids": "CDHOQSTUY", "Basic Residues": 9, "Acidic Residues": 2, "Hydrophobic Residues": 17, "Polar Residues": 21, "Positive Residues": 9, "Negative Residues": 2, "SPADE ID": "SPADE_UN_22447", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22446", "Similarity": 1.0, "Sequence": "MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG"}, {"SPADE_ID": "SPADE_UN_22447", "Similarity": 1.0, "Sequence": "MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG"}, {"SPADE_ID": "SPADE_N_06738", "Similarity": 0.9736842105263158, "Sequence": "LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG"}], "Hemolytic Activity": "Human fibroblasts WI-38:LD50=950 µg/ml,Human erythrocytes:50% Hemolysis=>1000 µg/ml,Human leukocytes:LD50=>500 µg/ml", "Target Organism": "Staphylococcus aureus ATCC 6538(MIC=>200µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC=100µg/ml),Saccharomyces cerevisiae(MFC=>200µg/ml),Escherichia coli ATCC 25922(MBC=50µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=>60µg/ml),Staphylococcus aureus ATCC 25923(MBC=75µg/ml),Human breast adenocarcinoma MCF-7(LD50=540µg/ml),Human colon adenocarcinoma SW480(LD50=>1000µg/ml),Human melanoma BMKC(LD50=>1000µg/ml),Human lung carcinoma H1299(LD50=720µg/ml),Human cervical carcinoma HeLa S3(LD50=>1000µg/ml),Human prostate adenocarcinoma PC-3(LD50=630µg/ml),Escherichia coli UB1005(MIC=1µg/ml),Salmonella enterica serovar Typhimurium(MIC=4µg/ml),Pseudomonas aeruginosa PAO1(MIC=16µg/ml),Pseudomonas aeruginosa M76(MIC=8µg/ml),Pseudomonas aeruginosa M917(MIC=16µg/ml),Pseudomonas aeruginosa M1251(MIC=4µg/ml),Pseudomonas aeruginosa M1426(MIC=8µg/ml),Pseudomonas aeruginosa R70(MIC=4µg/ml),Staphylococcus aureus(MIC=>128µg/ml),Candida albicans(MIC=>128µg/ml),Pseudomonas stutzeri(MIC=4µg/ml),Pseudomonas fluorescens(MIC=8µg/ml),Ralstonia pickettii(MIC=8µg/ml),Stenotrophomonas maltophilia(MIC=2µg/ml),Achromobacter xylosoxidans(MIC=32µg/ml)"}}}